The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Biomarker Discovery and Validation: Statistical Considerations
Open accessAbstract
Biomarkers have various applications including disease detection, diagnosis, prognosis, prediction of response to intervention, and disease monitoring. In this era of precision medicine, having validated biomarkers to inform clinical decision making is more important than ever. In this article, we discuss best the practices and potential issues in biomarker discovery and validation. We encourage team science partnerships to bring cutting-edge discovery from bench to bedside, leading to improved patient care and outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Elements of Statistical Learning
Hastie, T., Tibshirani, R., & Friedman, J. (2009) · Springer Series in Statistics · doi:10.1007/978-0-387-84858-7 · Cited by 25,970
Statistical Analysis With Missing Data
Lahiff, M., Little, R. J. A., & Rubin, D. B. (1989) · Journal of the American Statistical Association · doi:10.2307/2289883 · Cited by 17,265
The Elements of Statistical Learning: Data Mining, Inference, and Prediction
John Lu, Z. Q. (2010) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2010.00646_6.x · Cited by 12,390
Statistical significance for genomewide studies
Storey, J. D., & Tibshirani, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1530509100 · Cited by 9,692 · cited 1×
“Control of multiple comparisons should be implemented when multiple biomarkers are evaluated; a measure of false discovery rate is especially useful when using large-scale genomic or other high dimensional data for biomarker discovery.(17) During biomarker discovery, evaluation of associations between a biomarker and…”
BackgroundGefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Statistical Analysis With Missing Data
Ghosh, S. (1988) · Technometrics · doi:10.1080/00401706.1988.10488446 · Cited by 4,576
Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating
Steyerberg, E. W. (2019) · Statistics for Biology and Health · doi:10.1007/978-3-030-16399-0 · Cited by 3,281
An Introduction to Statistical Learning: with Applications in R
James, G. M., Witten, D., Hastie, T. J., & Tibshirani, R. J. (2018) · doi:10.25334/q4ht55 · Cited by 2,912
The Statistical Evaluation of Medical Tests for Classification and Prediction
Pepe, M. S. (2003) · doi:10.1093/oso/9780198509844.001.0001 · Cited by 2,198
Tackling the widespread and critical impact of batch effects in high-throughput data
Leek, J. T., Scharpf, R. B., Bravo, H. C., Simcha, D., Langmead, B., Johnson, W. E., Geman, D., Baggerly, K., & Irizarry, R. A. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2825 · Cited by 2,196
The Statistical Evaluation of Medical Tests for Classification and Prediction
(2005) · Technometrics · doi:10.1198/tech.2005.s278 · Cited by 1,899
Phases of Biomarker Development for Early Detection of Cancer
Pepe, M. S., Etzioni, R., Feng, Z., Potter, J. D., Thompson, M. L., Thornquist, M., Winget, M., & Yasui, Y. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1054 · Cited by 1,686
Marcus, L., Lemery, S. J., Keegan, P., & Pazdur, R. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4070 · Cited by 1,176
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Simon, R. M., Paik, S., & Hayes, D. F. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp335 · Cited by 1,037
Clinical Prediction Models: A Practical Approach to Development, Validation and Updating
Mann, C. J. H. (2009) · Kybernetes · doi:10.1108/k.2009.06738fae.002 · Cited by 783
Pepe, M. S., Feng, Z., Janes, H., Bossuyt, P. M., & Potter, J. D. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn326 · Cited by 717
Teutsch, S. M., Bradley, L. A., Palomaki, G. E., Haddow, J. E., Piper, M., Calonge, N., Dotson, W. D., Douglas, M. P., & Berg, A. O. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e318184137c · Cited by 680
Bias as a threat to the validity of cancer molecular-marker research
Ransohoff, D. F. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1550 · Cited by 487
Sozzi, G., Boeri, M., Rossi, M., Verri, C., Suatoni, P., Bravi, F., Roz, L., Conte, D., Grassi, M., Sverzellati, N., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.4357 · Cited by 436
Papillon-Cavanagh, S., Doshi, P., Dobrin, R., Szustakowski, J., & Walsh, A. M. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000706 · Cited by 235
Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
Boyiadzis, M. M., Kirkwood, J. M., Marshall, J. L., Pritchard, C. C., Azad, N. S., & Gulley, J. L. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0342-x · Cited by 219
Sources of Bias in Specimens for Research About Molecular Markers for Cancer
Ransohoff, D. F., & Gourlay, M. L. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.6065 · Cited by 201
Nicholson, A. G., Sauter, J. L., Nowak, A. K., Kindler, H. L., Gill, R. R., Remy-Jardin, M., Armato, S. G., Fernandez-Cuesta, L., Bueno, R., Alcala, N., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.08.2506 · Cited by 168
Biomarker studies: a call for a comprehensive biomarker study registry
André, F., McShane, L. M., Michiels, S., Ransohoff, D. F., Altman, D. G., Reis-Filho, J. S., Hayes, D. F., & Pusztai, L. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.4 · Cited by 118
Self-citationProgrammed death-1 blockade in mismatch repair deficient colorectal cancer.
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Azad, N. S., Laheru, D. A., Donehower, R. C., Crocenzi, T. S., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.103 · Cited by 106
Different prognostic impact ofSTK11mutations in non-squamous non-small-cell lung cancer
Pécuchet, N., Laurent‐Puig, P., Mansuet‐Lupo, A., Legras, A., Alifano, M., Pallier, K., Didelot, A., Gibault, L., Danel, C. J., Just, P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6379 · Cited by 93
Randomized Phase III Clinical Trial Designs for Targeted Agents
Hoering, A., LeBlanc, M., & Crowley, J. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0288 · Cited by 89
Advanced-Stage Non–Small Cell Lung Cancer: Advances in Thoracic Oncology 2018
Remón, J., Ahn, M., Girard, N., Johnson, M. L., Kim, D., Lopes, G. D. L., Jr., Pillai, R. N., Solomon, B., Villacampa, G. J., & Zhou, Q. H. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.03.022 · Cited by 88
Herbst, R. S., Redman, M. W., Kim, E. S., Semrad, T. J., Bazhenova, L. A., Masters, G. A., Oettel, K. R., Guaglianone, P. P., Reynolds, C., Karnad, A. B., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30694-0 · Cited by 81
Rudin, M. (2007) · European Radiology · doi:10.1007/s00330-007-0619-9 · Cited by 52
Refining Prognosis in Lung Cancer
Mahar, A. L., Compton, C. C., McShane, L. M., Halabi, S., Asamura, H., Rami–Porta, R., & Groome, P. A. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000652 · Cited by 43
Blocking and Randomization to Improve Molecular Biomarker Discovery
Qin, L., Zhou, Q. C., Bogomolniy, F., Villafania, L. B., Olvera, N., Cavatore, M., Satagopan, J. M., Begg, C. B., & Levine, D. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3155 · Cited by 19
Ou, F., An, M., Ruppert, A. S., & Mandrekar, S. J. (2019) · JCO Precision Oncology · doi:10.1200/po.19.00051 · Cited by 6
Self-citation
Cited by
Molecular Biomarkers in Cancer
Sarhadi, V. K., & Armengol, G. (2022) · Biomolecules · doi:10.3390/biom12081021 · Cited by 467
Ahmad, A., Imran, M., & Ahsan, H. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061630 · Cited by 386
Neuffer, J., González-Domínguez, R., Lefèvre-Arbogast, S., Low, D. Y., Driollet, B., Helmer, C., Du Preez, A., de Lucia, C., Ruigrok, S. R., Altendorfer, B., et al. (2022) · Nutrients · doi:10.3390/nu14214688 · Cited by 40
Metadata
- Authors
- Ou, F.-S., Michiels, S., Shyr, Y., Adjei, A. A., & Oberg, A. L.
- Venue
- Journal of Thoracic Oncology
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 16
- Issue
- 4
- Pages
- 537-545
- ISSN
- 1556-0864 (ISSN-L)
- OpenAlex
- W3126601778
- Cited by
- 258
- References
- 35
- FWCI
- 21.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.